MedTrace Logo

Thiamine Responsive Disorders (TRD) Among Infants in Lao PDR

NCT03626337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1394

Last updated 2022-08-15

No results posted yet for this study

Summary

A hospital- and community-based study in Luang Prabang, Lao PDR, which will include a group of hospitalized children 21 days to \<18 months of age who are diagnosed with symptoms compatible with thiamine deficiency disorder (TDD). Based on the infants' response to thiamine administration, children will be defined as either thiamine responsive disorder (TRD) cases or non-responders. A community-based comparison group of infants in the same age range will be included in the study to serve as a control group for identification of potential risk factors.

Conditions

  • Thiamine Deficiency

Interventions

DRUG

Thiamine 100 MG/ML

100 mg thiamine provided as intramuscular injection

Sponsors & Collaborators

  • Lao Tropical and Public Health Institute

    collaborator OTHER_GOV

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Sengchanh Kounnavong, MD, PhD · Lao Tropical and Public Health Institute

Eligibility

Min Age
21 Days
Max Age
17 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-17
Primary Completion
2021-02-25
Completion
2021-02-25

Countries

  • Laos

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03626337 on ClinicalTrials.gov